ZA981832B - Swallow tablet comprising paracetamol - Google Patents

Swallow tablet comprising paracetamol

Info

Publication number
ZA981832B
ZA981832B ZA981832A ZA981832A ZA981832B ZA 981832 B ZA981832 B ZA 981832B ZA 981832 A ZA981832 A ZA 981832A ZA 981832 A ZA981832 A ZA 981832A ZA 981832 B ZA981832 B ZA 981832B
Authority
ZA
South Africa
Prior art keywords
paracetamol
swallow tablet
swallow
tablet
Prior art date
Application number
ZA981832A
Other languages
English (en)
Inventor
Timothy James Grattan
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ZA981832B publication Critical patent/ZA981832B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/485Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
ZA981832A 1997-03-05 1998-03-04 Swallow tablet comprising paracetamol ZA981832B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9704524.9A GB9704524D0 (en) 1997-03-05 1997-03-05 Composition

Publications (1)

Publication Number Publication Date
ZA981832B true ZA981832B (en) 1998-12-11

Family

ID=10808717

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA981832A ZA981832B (en) 1997-03-05 1998-03-04 Swallow tablet comprising paracetamol

Country Status (36)

Country Link
US (1) US6316025B1 (xx)
EP (1) EP0981334B1 (xx)
JP (1) JP2001513801A (xx)
KR (1) KR100465895B1 (xx)
CN (1) CN100389751C (xx)
AP (1) AP1084A (xx)
AR (1) AR011919A1 (xx)
AT (1) ATE240720T1 (xx)
AU (1) AU721851B2 (xx)
BG (1) BG64348B1 (xx)
BR (1) BR9807992A (xx)
CA (1) CA2283408C (xx)
CO (1) CO4940406A1 (xx)
CY (1) CY2367B1 (xx)
CZ (1) CZ294078B6 (xx)
DE (1) DE69814850T2 (xx)
DK (1) DK0981334T3 (xx)
EA (1) EA001918B1 (xx)
ES (1) ES2199435T3 (xx)
GB (1) GB9704524D0 (xx)
HK (1) HK1027026A1 (xx)
HU (1) HU224983B1 (xx)
ID (1) ID22233A (xx)
IL (1) IL131552A (xx)
MY (1) MY119722A (xx)
NO (1) NO327456B1 (xx)
NZ (1) NZ337418A (xx)
PE (1) PE68899A1 (xx)
PL (1) PL190988B1 (xx)
PT (1) PT981334E (xx)
SK (1) SK282277B6 (xx)
TR (1) TR199902175T2 (xx)
TW (1) TW508242B (xx)
UA (1) UA59388C2 (xx)
WO (1) WO1998038983A2 (xx)
ZA (1) ZA981832B (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6211246B1 (en) 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
NZ508291A (en) * 1999-11-24 2002-09-27 Mcneil Ppc Inc Use of acetaminophen in a medicament for treating migraine symptoms
GB0006897D0 (en) * 2000-03-23 2000-05-10 Smithkline Beecham Plc Medicaments
GB0114069D0 (en) * 2001-06-08 2001-08-01 Smithkline Beecham Plc Composition
GB0129117D0 (en) * 2001-12-05 2002-01-23 Glaxo Group Ltd Pharmaceutical composition
JP2006522790A (ja) * 2003-04-11 2006-10-05 ファイザー・インク エレトリプタンと重炭酸ナトリウムを含む医薬組み合わせ物
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
ES2624585T3 (es) * 2004-05-28 2017-07-17 Imaginot Pty Ltd. Sistema de suministro de compuesto terapéutico oral
AU2005247047C1 (en) * 2004-05-28 2010-03-11 Glaxo Group Limited Oral delivery system
DE102004042139B4 (de) * 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
PT1807068E (pt) * 2004-10-28 2010-04-19 Novartis Ag Composição que inclui acetaminofeno, cafeína e opcionalmente aspirina em conjunto com um agente alcalino de forma a realçar a absorção
US9060950B2 (en) * 2005-06-13 2015-06-23 Paul H. Rosenberg, Proximate Concepts, LLC. Emetic embedded capsule
WO2006138278A1 (en) * 2005-06-13 2006-12-28 Paul Rosenberg Emetic embedded capsule
KR100702069B1 (ko) * 2005-10-31 2007-03-30 (주)이엘티사이언스 파라세타몰 경구용 수용산제 복합조성물 및 그 제조방법
AU2006317530B2 (en) 2005-11-28 2011-09-01 Imaginot Pty Ltd Oral therapeutic compound delivery system
GB0607085D0 (en) * 2006-04-07 2006-05-17 Smithkline Beecham Corp Novel compositions
WO2008008120A1 (en) * 2006-07-14 2008-01-17 Fmc Corporation Solid form
US20080311162A1 (en) * 2007-05-16 2008-12-18 Olivia Darmuzey Solid form
US20110098359A1 (en) * 2007-08-07 2011-04-28 Stellenbosch University Compositions and Methods for Treatment of Glaucoma
KR101687580B1 (ko) 2016-07-19 2016-12-20 주식회사 씨.월드 의자 등받이부와 프레임부 조립구조
JP7472116B2 (ja) 2018-11-19 2024-04-22 ジャズ ファーマシューティカルズ アイルランド リミテッド 耐アルコール性製剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1182049A (en) * 1981-07-13 1985-02-05 Francis J. Sterbenz Apap antacid composition
EP0377906B1 (en) * 1989-01-12 1993-12-15 Bayer Ag Effervescent analgesic antacid composition having reduced sodium content
US4942039A (en) * 1989-05-09 1990-07-17 Miles Inc. Effervescent analgesic antacid composition having reduced sodium content
US5348745A (en) * 1989-05-09 1994-09-20 Miles Inc. Aqueous granulation solution and a method of tablet granulation
CA2021548A1 (en) * 1989-09-01 1991-03-02 Ronald Nash Duvall Effervescent cold or sinus allergy medicine composition having reduced sodium content
DE19502789A1 (de) 1995-01-28 1996-08-01 Dirk Krischenowski Arzneimittel

Also Published As

Publication number Publication date
SK119799A3 (en) 2000-02-14
GB9704524D0 (en) 1997-04-23
AR011919A1 (es) 2000-09-13
DE69814850T2 (de) 2004-03-11
BG103714A (en) 2000-05-31
EP0981334B1 (en) 2003-05-21
CN1253497A (zh) 2000-05-17
UA59388C2 (uk) 2003-09-15
CA2283408A1 (en) 1998-09-11
KR20000075897A (ko) 2000-12-26
CN100389751C (zh) 2008-05-28
ATE240720T1 (de) 2003-06-15
AU6828298A (en) 1998-09-22
ID22233A (id) 1999-09-23
JP2001513801A (ja) 2001-09-04
DE69814850D1 (de) 2003-06-26
MY119722A (en) 2005-07-29
PL190988B1 (pl) 2006-02-28
TR199902175T2 (xx) 1999-12-21
IL131552A (en) 2004-08-31
CZ314899A3 (cs) 2000-03-15
US6316025B1 (en) 2001-11-13
HK1027026A1 (en) 2001-01-05
EA199900709A1 (ru) 2000-08-28
CY2367B1 (en) 2004-06-04
AU721851B2 (en) 2000-07-13
BG64348B1 (bg) 2004-11-30
PL335502A1 (en) 2000-04-25
HUP0001501A3 (en) 2001-01-29
HU224983B1 (en) 2006-05-29
EA001918B1 (ru) 2001-10-22
WO1998038983A2 (en) 1998-09-11
SK282277B6 (sk) 2002-01-07
BR9807992A (pt) 2000-03-08
AP1084A (en) 2002-07-23
CZ294078B6 (cs) 2004-09-15
PT981334E (pt) 2003-10-31
AP9901638A0 (en) 1999-09-30
NO994294D0 (no) 1999-09-03
KR100465895B1 (ko) 2005-01-13
CA2283408C (en) 2007-01-02
EP0981334A1 (en) 2000-03-01
ES2199435T3 (es) 2004-02-16
HUP0001501A2 (hu) 2000-09-28
NZ337418A (en) 2000-05-26
NO327456B1 (no) 2009-07-06
DK0981334T3 (da) 2003-09-22
TW508242B (en) 2002-11-01
IL131552A0 (en) 2001-01-28
NO994294L (no) 1999-09-03
PE68899A1 (es) 1999-09-26
WO1998038983A3 (en) 1998-12-17
CO4940406A1 (es) 2000-07-24

Similar Documents

Publication Publication Date Title
PL340337A1 (en) Drugs
AP9901638A0 (en) Swallow tablet comprising paracetamol
ZA987551B (en) Solid pharmaceutical dosage forms
GB9814501D0 (en) Medication dosage reminder device
ZA9811504B (en) Novel pharmaceutical.
GB9726566D0 (en) Novel pharmaceutical
EP1145714A4 (en) DRUGS
EG23694A (en) Novel pharmaceutical
AU137637S (en) A pharmaceutical tablet
AU134671S (en) Pacifier
GB9725219D0 (en) Tablets
IL121696A0 (en) Pacifier
SI0981334T1 (en) Swallow tablet comprising paracetamol
GB9706376D0 (en) Novel pharmaceutical
CA80343S (en) Pharmaceutical tablet
CA84666S (en) Pharmaceutical tablet
CA83558S (en) Pharmaceutical tablet
CA80450S (en) Tablet
CA80449S (en) Tablet
CA80217S (en) Tablet
AU134179S (en) Tablet
AU134228S (en) Tablet
GB9717420D0 (en) Pill monitor
GB9725661D0 (en) Ptient-prompted medication
GB9605234D0 (en) Pharmaceutical tablet